Eugeen Vanmechelen

12PUBLICATIONS
55CO-AUTHORS
Sensory processes, perception and performanceGene expression (incl. microarray and other genome-wide approaches)Social and affective neurosciencePredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 22, 2025
Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer's disease and Parkinson's disease.

|Jan 09, 2024
Cerebrospinal fluid proteomics in patients with Alzheimer's disease reveals five molecular subtypes with distinct genetic risk profiles.

Betty M Tijms, Ellen M Vromen, Olav Mjaavatten

|Oct 29, 2023
Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuum.

Julie Goossens, Alba Cervantes González, Nele Dewit

|Dec 01, 2022
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring.

Nicholas J Ashton, Shorena Janelidze, Niklas Mattsson-Carlgren

|Nov 16, 2022
Bioinformatics tools and data resources for assay development of fluid protein biomarkers.

Katharina Waury, Eline A J Willemse, Eugeen Vanmechelen

|Sep 13, 2022
Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease.

Marta Milà-Alomà, Nicholas J Ashton, Mahnaz Shekari

Pageof 2

Frequent Collaborators

4 joint publications

Henrik Zetterberg

3 joint publications

Thomas K Karikari

3 joint publications

Kaj Blennow

3 joint publications

Charlotte E Teunissen